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Abstract. We analyzed the binding of fibronectin to 
integrin a5/31 in various cells; in some cells fibronectin 
bound with low affinity (e.g., K562 cells) whereas in 
others (e.g., CHO), it bound with high affinity (Kd ,~ 
100 nM) in an energy-dependent manner. We con- 
structed chimeras of the extracellular nd transmem- 
brane domains of c~3 joined to the cytoplasmic do- 
mains of otsBl. The affinity state of these chimeras was 
assessed by binding of fibrinogen or the monoclonal 
antibody, PACl. The cytoplasmic domains of 0~5/~ con- 
ferred an energy-dependent high affinity state on otnbB3 
in CliO but not K562 cells. Three additional tx cyto- 
plasmic domains (ix2, otv~, ot~B) conferred PAC1 bind- 
ing in CHO cells, while three others (otM, OiL, av) did 
not. In the high affinity ot chimeras, cotransfection 
with a truncated (~3A724) or mutated (~3(S752"-~P)) 83 
subunit abolished high affinity binding. Thus, both cy- 
toplasmic domains are required for energy-dependent, 
cell type-specific affinity modulation. In addition, mu- 
tations that disrupted a highly conserved o~ subunit 
GFFICR motif, resulted in high affinity binding of 
ligands to Otnb/~3. In contrast to the chimeras, the high 
affinity state of these mutants was independent of cel- 
lular metabolism, cell type, and the bulk of the ~ sub- 
unit cytoplasmic domain. Thus, integrin cytoplasmic 
domains mediate inside-out signaling. Furthermore, ' 
the highly conserved GFFKR motif of the c~ Subunit 
cytoplasmic domain maintains the default low affinity 
state. 
C 
ELLS alter their adhesiveness in response to devel- 
opmental events or environmental cues. These adap- 
tations are often mediated through integrins, adhe- 
sion receptors composed of two transmembrane subunits, ct 
and B (43). Rapid changes in integrin function are critical in 
cell migration, cellular aggregation, and leukocyte trans- 
migration during inflammation (2, 24, 31, 36, 43, 75, 86). 
A given integrin may also manifest varying adhesive compe- 
tence depending on its cellular environment (15, 25, 49, 62, 
94), or the state of differentiation fthe cell (1, 15, 35, 66). 
Such variations in function may be due to changes in ligand- 
binding affinity as occurs with certain/~3 (7), B2 (4), and/~ 
(26) integrins. Changes in adhesive function may also occur 
without changes in ligand-binding affinity. For example, 
phorbol esters stimulate the o~s/3~-dependent adhesion of 
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CHO ceils (20) to fibronectin (Fn) ~ with no change in Fn- 
binding affinity. Similarly, certain /33 mutations reduce 
Otnb/33-dependent stabilization of cell adhesion to fibrinogen 
(Fg) without changing intrinsic Fg-binding affinity (97). 
Such affinity-independent changes in integrin function are 
ascribed to "post receptor events" (20). Nevertheless, the 
host cell governs the capacity of solubilized ot2Bl to bind to 
immobilized ligands (49). This last result suggests hat some 
cell type-specific differences inintegrin function may be due 
to differences in ligand-binding affinity. 
anbl33 (platelet GPllb-KIa) is a prototype integrin for anal- 
ysis of changes in integrin affinity. As with all integrins, 
~Xnbi33 is a heterodimer of two Type I transmembrane pro- 
tein subunits (43), o~iroB3 is platelet-specific (88), and af- 
finity state-specific antibodies, e.g., PAC1 (81), simplify 
analysis of recombinant oLnb~3 in heterologous cells (67). 
Conformational changes in the extracellular domain of OtnbB~ 
regulate its affinity (67, 82). Platelet agonists increase the 
affinity of Oel~3 (U~activation') viacytoplasmic signaling path- 
ways. These pathways include heterotrimeric GTP-binding 
proteins, phospholipid metabolism, and serine-threonine ki- 
nases and may also involve calcium fluxes, tyrosine kinases, 
1. Abbreviations used in this paper: Fg, fibrinogen; Fn, fibronectin. 
© The Rockefeller University Press, 0021-9525/94/03/1047/13 $2.00 
The Journal of Cell Biology, Volume 124, Number 6, March 1994 1047-1059 1047 
and low molecular weight GTP-binding proteins (31, 32, 65, 
79, 80, 82). How cytoplasmic signals result in changes in the 
conformation and ligand-binding affinity of the extracellular 
domain ("inside-out signal transduction") of the integrin re- 
mains obscure. 
A variety of in vitro treatments may alter integrin affinity. 
When purified O~nb/33 is pretreated with RGD peptides, it 
subsequently binds Fg and PAC1 (23, 50, 85). Certain 
anti-/33 antibodies directly increase the Fg-binding affinity 
of Otnb~3 (29) and certain anti-fit antibodies activate asBt to 
bind Fn with high affinity (26). Changes in the divalent cat- 
ion composition of the extracellular medium, proteolytic 
digestion, and treatment with reducing agents may also "acti- 
vate" integrins (3, 30, 34, 48, 62, 94, 98). Thus, moieties that 
interact with the extracellular domain can modulate integrin 
affinity. Furthermore, lipid environment can alter an inte- 
grin's ligand-binding capacity 07, 85) and an apparently 
novel lipid, IMF-1, may regulate o~M/32 (37). Although many 
treatments may change integrin affinity in vitro, the mecha- 
nism(s) of physiological modulation has not been defined. 
Integrin cytoplasmic domains may be targets of cytoplas- 
mic signals that alter integrin affinity. The cytoplasmic tails 
are ,~180 A from the ligand-binding site (93), but integrins 
can undergo propagated long-range conformational changes 
in situ (22). Truncation of the ott~ cytoplasmic domain after 
residue 990 (~nbA991) results in otnb/~3 that constitutively 
binds Fg and PAC1 (69). Conversely, truncations of or4 (45), 
or2 (46), and/~2 (39) profoundly reduce the capacity of these 
integrins to mediate cell adhesion, possibly due to effects on 
ligand-binding affinity. Such truncations may result in mis- 
folded receptors that lack function or that bind ligands with 
an inappropriately high affinity. Furthermore, a Ser 752 to 
Pro mutation in the #3 cytoplasmic domain was associated 
with an apparent o~/33 activation defect (16) in a single in- 
dividual. Cytoplasmic domains of several integrins are phos- 
phorylated coincidentally with increases in adhesive func- 
tion. Nevertheless, detailed studies (38, 40) have so far failed 
to establish a role for these phosphorylations in increased 
affinity. Conversely, the rounding of cells during mitosis is 
associated with phosphorylation of fit and reduced binding 
of ots/3t o Fn (43). Thus, physiological activation signals 
may be transmitted through integrin cytoplasmic domains, 
but definitive proof is lacking. 
In the present work, we tested the hypothesis that integrin 
cytoplasmic domains are directly involved in physiological 
affinity modulation. Using chimeras containing the cytoplas- 
mic domains of various a and/~ subunits joined to the trans- 
membrane and extracellular domain of o~3,  we found that 
integrin cytoplasmic domains transduce cell type-specific 
signals that modulate ligand-binding affinity. These signals 
require active cellular processes and both ot and/~ cytoplas- 
mic tails of the integrin, suggesting that they represent phys- 
iologically relevant signals. In addition, deletion of a highly 
conserved GFFKR motif, at the NH2 terminus of the ot 
subunit cytoplasmic domain, also resulted in high affinity 
binding of ligands to otm~3. In contrast to the chimeras, 
high affinity ligand binding to GFFKR deletion mutants was 
independent of cellular metabolism, cell type, and the bulk 
of the/3 subunit cytoplasmic domain. Thus integrin cytoplas- 
mic tails are targets for the modulation of integrin affinity. 
Materials and Methods 
Antibodies and Reagents 
The anti-cmbB3 antibody D57 was produced by Dr. Xiaoping Du (Scripps 
Research Institute) using previously described methods (28). It binds to 
CHO ceils transfected with ~nb~3 but not O~v~3, and does not block Fg 
binding to Otnb~3. This antibody was biotinylated with biotin-N-hydroxy- 
succiuimide (Sigma Chem. Co., St. Louis, MO) according to manufac- 
turers directions. The C~nb/33 complex specific antibody, 2(312 (71), was 
supplied by Dr. Vhgil Woods (University of California, San Diego) and 
used as dilutions of ascites fluid. The anti-hamster a5 (PB1) and anti-/~t 
(7E2) antibodies were obtained from Dr. Rudolph Juliano (10) (University 
of North Carolina, Chapel Hill), and the/~t activating antibody, 8A2, was 
supplied by Drs. Nick Kovach and John Harlan (51) (University of Washing- 
ton, Seattle). A human anti-c5 antibody, BIIG2, was supplied by Dr. Caro- 
line Damsky (95) (University of California, San Francisco) while a poly- 
clonal anti-peptide antibody against the cytoplasmic domain of human ~5 
(44) was obtained from Drs. Gene Marcantonio and Richard Hynes (Mas- 
sachusetts Institute of Technology, Boston). The isolation and characteriza- 
tion of other antibodies (anti-LIBS6, anti-LIBS2, anti-c~wo cytoplasmic 
domain [28, 69]) and PAC1 (81) have been described. Glucose and 2-deoxy- 
glucose were purchased from Sigma and sodium azide was from Fisher Sci- 
entific Co. (Pittsburgh, PA). The peptide GRGDSP was obtained from 
Peninsula Laboratories (Belmont, CA). Its purity and composition were 
verified by high performance liquid chromatography and fast atom bom- 
bardment mass spectroscopy. 
Cell Culture and Transfection 
The human cell lines K562, U937, WI38, and MG63 were obtained from 
the Amer. Type Culture Collection (Rockville, MD) and maintained in
RPMI 1640 media (Biowhittaker, Walkersville, MD) containing 10% FBS 
(Biowhittaker), 1% glutamine (Sigma), and 1% penicillin and streptomycin 
(Sigma). THlXl cells (Amer. Type Culture CoUection) were maintained in
the same medium with the addition of 10 mM Hepes and 20 mM 2-mercap- 
toethanol. CHO cells (Amer. Type Culture Collection) were maintained in
DMEM media (Biowhittaker) with 10% FCS, the above noted antibiotics, 
and 1% non-essential amino acids (Sigma). Human T lymphocytes were 
purified from peripheral blood of normal donors by centrifngation  a 
Ficoll-Paque gradient (Pharmacia Fine Chemicals, Piscataway, NJ), pan- 
ning for monocytes on serum-coated dishes, and passage over a nylon wool 
column. 
CHO cells were transiently transfected by electroporation. Cells in log 
phase growth were harvested with trypsin (Irvine Scientific), washed with 
PBS, and combined with appropriate cDNAs (10 ttg each subunit). 3 x 
107 cells in 0.5 ml in growth media were electroporated at350 V, 960/~F 
in a BTX (BTX, San Diego, CA) ciectroporator. Media were changed after 
24 h, and cells analyzed for surface xpression or PAC1 binding aRer 48 
h. Stable CHO transfectants were established asabove with cotransfeetion 
of 0.6/~g of CDNeo. After 48 h, these cells were selected for 2 wk in 700 
/~g/ml G418 (GIBCO BRL, Gaithershnrg, MD) and clonal ines were estab- 
lished by single cell sorting in a FACStar (Becton Dickinson Immunocytom- 
etry Sys., Mountain View, CA). Stable K562 transfectants were established 
by electroporafion of 107 cells in 0.8 ml of PBS at 300 V and 500/~F. After 
48 h, the cells were maintained in media containing 1mg/ml O418, and 
clonal ines established by limiting dilution cloning. 
Flow Cytometry 
Surface expression of integrins was analyzed by flow cytometry with 
specific antibodies as described (57, 68). Briefly, 5 x 105 cells were in- 
cuhated on ice for 30 rain with primary antibody, washed, and then in- 
cuhated on ice for 30 rain with an FITC-conjugated goat anti-mouse ('lhgo, 
Buriingame, CA) second antibody. Cells were pelleted, resuspended, and 
analyzed on a FACScan (Becton Dickinson Immunocytometry Sys.). PAC1 
binding was analyzed by two color flow cytometry. Cell staining was carried 
out in Tyrode's (33) buffer containing 2 mM MgCIz and CaCI2 and 1 
mg/rrd BSA (Sigma) and dextrose. Single cell suspensions were obtained 
by harvesting with 3.5 mM EDTA, incubating for 5 rain in 1 mg/mi TPCK 
trypsin (Worthington) and diluting with an equal volume of Tyrode's con- 
taining 10% FCS and 0.1% soybean trypsin inhibitor (Sigma). After wash- 
ing, 5 × 105 cells were incubated in a final volume of 50 t~l containing 
The Journal of Cell Biology, Volume 124, 1994 1048 
0.1% PAC1 ascites in the presence or absence of 1 mM GRGDSP peptide. 
After a 30-rain incubation at room temperature, cells were washed with cold 
Tyrode's olution and then incubated on ice with biotinylated antibody D57. 
After 30 m/n, cells were washed and then incubated on ice with Tyrode's 
containing 10% F1TC-conjugated goat anti-mouse IgM (Tago) and 4% 
phyeoerythrin-streptavidin (Molecular Probos Inc., Junction City, OR). 
Thirty minutes later cells were diluted to 0.5 mi with Tyrode's olution and 
analyzed on a FACScan (B¢cton Dickinson) flow cytometer as described 
(67). PAC1 binding (FITC staining) was analyzed only on a gated subset 
of ceils positive for an~3 expression (phycoerythrin staining). To define 
affinity state, histograms depietiog PAC1 staining in the absence or presence 
of 1 mM GRGDSP were supo'imposed. Since RGD peptides are inhibitors 
of PAC1 binding to am,/~3 (8), a rightward shift in the histogram in the ab- 
sence of peptide is indicative of the presence of high affinity c~,~3. To 
compare the effects of multiple a subunits, pooling of data involving experi- 
ments from different days, was required. To do this, a numerical activation 
index was defined as: 
100*(F0-FR)/FR where: 
Fo = Mean Fluorescence Intensity in the absence of inhibitor 
FR = Mean Fluorescence Intensity in the presence of GRGDSP 
Expression of am/~3 in transiently transfected K562 cells was too low to 
permit affinity state analysis. Thus, all data reported with these cells is from 
stable lines. The truncation mutant, am,A991, like a similar aL truncation 
(39), was expressed atlow levels in transient transfections, sothat all data 
obtained with this mutant refer to stable call lines. In contrast the aLA 
variant was well expressed, so that data from both transient and stable ex- 
periments are reported. Stable cell lines were also prepared with the follow- 
ing cytoplasmic domain combinations anb/~3, ~s/~3, cts/~sA724, a~3,  and 
ot~3A728. The data with the stable cell lines confirmed the findings in 
transient analyses. All other combinations were tested in transient transfee- 
tions only. 
DNA Constructs 
The generation of CDM8 constructs encoding am,, a,m,A991, alr~A996,/33, 
and ~3A728 have been previously described (68, 69, 97). The B3 trunca- 
tion, A724, and amino acid substitution, $752~P, were first generated in
BS3a (68) by oligonucleotide-direeted mutagenesis (52), digested with 
HincII to isolate coding sequences, ligated to BstXI linkers, flnvitrogen, 
San Diego, CA) and subcloned into the BstXI sites of CDMS. The #3 chi- 
mera, containing the/~l cytoplasmic domain, was constructed by first gen- 
erating an EcoRl site at bases 2387-2392 of /~ eDNA sequence. After 
HindlII digestion, a400-bp fragment containing the complete #1 cytoplas- 
mic domain and partial 3' non-coding sequences was isolated and subcloned 
into the HindlH site of CDMS. This construct was then digested with EcoRl 
and ligated with a 2.2-kb EeoRI fragment from CD3a (68) containing its 
transmembrane and extracellniar domains./~2 cytoplasmic sequences were 
first isolated by the PCR from a B2 eDNA, and then subcloned into the 
MluI and XhoI sites of CDMS. The B2 cytoplasmic domain chimera was 
then generated by digestion with MluI and HindlIl and ligation with a corre- 
sponding MluI-HindlIl fragment from CD3a containing its extraceUular 
and transmernbrane sequences. Chimeric a subunits were generated using 
a previously described strategy (69). Cytoplasmic sequences from t~v, c~, 
aL, a2, ot6A, and a~B were isolated from the appropriate eDNA clones by 
PCR (57). Amplified products were digested with HindIII and XbaI and 
subcloned into HindlII and Xbal cut CDMS. After digesting with HindlH, 
these constructs were ligated with a HindIll fragment from CD2b (68) con- 
talning its extracellular nd transmembrane domains. PCR oligonucleotides 
for aLA were designed to omit the VGFFK sequence. Its construction fol- 
lowed the procedure for other a chimeras. The a~ variant was made by 
first generating a SalI site in CD2b coding sequences corresponding to bases 
3061-3066. This vector was then digested with SalI and XbaI and ligated 
to a Sall-Xbal Blueseript vector sequence (bases 674-731). All constructs 
were verified by DNA sequencing and purified by CsCI centrifugation be- 
fore transfection. Oligonucleotides were synthesized on a model 391 DNA 
Synthesizer (Appl. Biosystems Inc., Foster City, CA). 
Ligand Binding 
The binding of 125I-Fg or t25I-Fn to cultured cells was accomplished asde- 
scribed (26, 67). Cells were harvested with EDTA and trypsin as described 
above for flow cytometry and resuspended in a modified Tyrode's buffer (150 
raM NaCI, 2.5 mM KCI, 2 mM NaHCO3, 2 mM MgCl2, 2 mM CaCl2, 
1 rag/m/BSA, and 1 rag/m/dextrose). A typical assay included 120 #1 of 
ceils (2 X I06 ceils per tube), 40/~I of radiolaboled protein, and 40/zl of 
inhibitor (GRGDSP peptide, blocking antibodies) or agonist (activating an- 
tibody). After 30 rain at room temperature, 50-~I aliquots were layered in 
triplicate on 0.3 ml of 20% sucrose and centrifuged for 3 m/n at 12,000 rpm. 
125I-labeled protein associated with the cell pellet was determined by scin- 
tillation spectrometry. Nonsaturable binding was determined in the pres- 
ence of 2 mM GRGDSP peptide. Data were fit to equilibrium binding 
models by the nonlinear least squares curve-fitting LIGAND program (64). 
In binding experiments u ing metabolic inhibitors, the cells were first in- 
cubated with 2 rag/m/2-deoxyglucose and0.1% sodium azide for 30 rain 
at room temperature b fore addition of radiolabeled ligand. In washout ex- 
periments, cells treated in this way were washed, incubated with Tyrode's 
containing 1 rag/m/dextrose for30 min at room temperature, and then ana- 
lyzed for ligand binding. 
lmmunoprecipitation 
Transfectants were surface labeled by the Iodogen method according to the 
manufacturer's in tructions (Pierce Chem. Co., Rockford, IL) and solubi- 
lized in lysis buffer (10 mM Hepes (pH 7.5), 0.15 M NaC1, 50 mM octyl- 
glucoside, 1mM CaCI2, 1 mM MgCI2, 1 mM phenylmethylsulfonyl fluo- 
ride, 0.I mM leupeptin, and 10 mM N-ethylmaieimide). Cell extracts were 
immunoprecipitated with polyelonal antiserum directed against the a~ or 
c~5 cytoplasmic domains and a monoclonal antibody against he am~3 
complex (2G12). The antibodies were attached onto preswollen protein 
A-Sepharose beads (Pharmacia LKB Bioteelmology Inc., Piscataway, NJ) 
by incubation at 4°C overnight. The antibody-conjugated S pharose beads 
were washed, pelleted by centrifugation, and then incubated with the deter- 
gent lysates from the surface labeled cells overnight with shaking. The 
Sepharose beads were washed extensively in lysis buffer, resuspended in 
sample buffer (53), and boiled for 5 min. After centrifugatlon, the precipi- 
tated protein was resolved by SDS-PAGE (non-reducing, Z5 % acrylamide 
gels). Gels were dried, and radiolabeled polypeptides were visualized by 
autoradiography. 
Polymerase Chain Reaction 
Total RNA was isolated from 106 transfected cells using the RNAzol re- 
gent  (Cirma Biotecx). First strand eDNA synthesis from 5 ~g of RNA was 
performed with the eDNA cycle kit (Invitrogan) using oligo dT as a primer. 
Coding sequences downstream of the am transmembrane region were 
specifically amplified with a 5' primer specific for transmembrane ctm 
(2bsf: CGGGCC~GGAGA~CATTC)  and 3'primers specific for 
the cytoplasmic sequences of otab (aabcyt: CTCTGI~oC_d3A~-  
CGA) and cx5 a~cyt: TGTAAACAAGC~TCCTTCAC). Amplified products 
were analyzed by agarose gel electrophoresis. 
Results 
Cell l)~e-Specific and Enemy-dependent Affinity 
Modulation of lntegrin aJB~ 
As noted above, there is evidence for cell type-specific con- 
trol of the adhesive function of integrins. To begin to inves- 
tigate the cell type-specific control of ligand-binding affinity, 
we first analyzed the binding of soluble Fn to cells expressing 
integrin o~5~. The cells analyzed fell into two groups: those 
that bound Fn with only low affinity (Kd >1/~M), e.g., K562, 
THP1, U937, and peripheral blood T cells, and those that 
bound with moderate affinity (Kd ",,100 nM), e.g., CHO, 
WI-38, and MG63 cells (Fig. 1 A). The low affinity o~/~1 
was intrinsically functional since it bound Fn after activation 
with the 8A2 monoclonal antibody (26) (Fig. 1 A) and was 
expressed at comparable l vels to high affinity CtsB~ (Fig. 1 
B). Specificity of Fn binding to high affinity as/~t was 
verified by inhibition with an anti c~5 antibody (Fig. 1 A). 
To find out whether spomaneous high affinity Fn binding 
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Figure L The high affinity state of as/~ is cell type-specific and 
energy-dependent. (.4) t25I-Fn (50 nM) was incubated at 22°C 
with CHO or K562 cells. After 30 min, bound Fn was assessed by 
centrifugation through a sucrose cushion as described in Materials 
and Methods. ,sB~-specific binding was established by blocking 
binding to the CHO cells with PB1, an anti-hamster ~'s. Binding to 
K562 cells was induced by addition of 20 nM activating antibody 
(842) and was inhibited by the anti-as, BIIG2. (B) The level of 
surface xpression of asfl~ in the two cell types. CHO and K562 
cells were stained with irrelevant mouse IgG (dotted line), an anti- 
/3~ antibody (K562:SA2, CHO:7E2) (solid line), or an anti-o~5 anti- 
body (K562:BIIG2, CHO:PB1) (dashedline), and then analyzed by 
flow cytometry as described in Materials and Methods. (C) The 
binding of ~25I-Fn to CHO cells (Resting), to cells incubated in 
9~,  
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Figure 2. Amino acid sequences of wild-type and variant integrin 
cytoplasmic domains. Single letter amino acid code is used. The 
arrows underneath t e am (residue 990) and B3 (residue 727) se- 
quences denote the position at which chimeric cytoplasmic do- 
mains were joined to the extracellular nd transmembrane domains 
of ~o and ~3. The position of stop codons producing cytoplasmic 
truncations are noted by triangles, while the $752"~P point muta- 
tion in/~3 is indicated. The residues deleted in the at.A cytoplas- 
mic domain are overlain by the heavy line. 
to o~5fll is an active process, we treated CHO cells with a 
combination of inhibitors of oxidative phosphorylation (NaN3) 
and anaerobic glycolysis (2-deoxyglucose). This resulted in 
loss of specific high affinity Fn binding. This effect was par- 
tially reversible since washout of the metabolic inhibitors re- 
sulted in restoration of 75 % of the high-affinity binding (Fig. 
1 C). Thus, high affinity Fn binding to integrin as#, is cell 
type-specific and an active cellular process. 
The Cytoplasmic Domains of a~ Confer an 
Energy-dependent High Affinity State on Olr~fl~ in 
Some Cells but Not Others 
To decide whether the cytoplasmic domains of olsB~ were 
involved in cell type-specific affinity modulation, we gener- 
ated chimeras in which the cytoplasmic domains of Otnb and 
t3 were replaced with the corresponding sequences from o~5 
and fl~ (Fig. 2). The ot and fl chimeras were then cotrans- 
fected into CHO or K562 cells, and the affinity state of the 
extraceUular a~3 reporter group was assayed by binding 
of PAC1, an antibody specific for the high affinity state of 
ot~3 (81). The double chimera bound PAC1 when it was 
expressed in CHO cells (Fig. 3). Since wild-type o~/33 
does not bind PAC1 when expressed in CHO cells (67), it is 
concluded that the Otsfl, cytoplasmic domains conferred the 
high affinity state on O~nbfl3. In sharp contrast, PAC1 did not 
bind to the double chimera in K562 cells. However, PAC1 
medium containing 2 mM deoxyglucose and 0.1% sodium azide 
(DOG/Az), or to ceils washed free of these inhibitors and returned 
to glucose-containing medium (Wash + Glc) was determined. 
Specificity of binding to ~,fll was verified by inhibition with the 
PB1 antibody. 
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Figure 3. Chimeric integrin constructs manifest cell type-specific 
affinity states. (A) FACS analysis. CHO or K562 cells were stably 
transfected with the chimeras containing the cytoplasmic domains 
of ~5 and/~l and the affinity state of he C~nb/~3 extracellular domain 
was assayed by its ability to bind PAC1 in the absence (solid line) 
or presence (dotted line) of 1 mM GRGDSP. Depicted are flow 
cytometry histograms. The K562 transfectants specifically bound 
PAC1 only after incubation with 6 ttM activating antibody, anti- 
LIBS 6. (B) lmmunoprecipitation analysis of K562 transfectants. 
Wild-type K562 cells (None) or stable transfectants expressing the 
c~ subunit noted (air, as = c~5 cytoplasmic domain chimera) were 
surface iodinated, lysed, and immunoprecipitated with polyclonal 
antibodies specific for the or5 and Ol,b cytoplasmic domains or with 
a monoclonal antibody reactive with the extracellular domain of 
tXnb/33 (2G12). Immunoprecipitates were resolved by SDS-PAGE 
and constituent polypeptides were visualized by autoradiography. 
(C) Reverse transcdptase-polymerase chain reaction (RT-PCR). 
The location of the 2bsf, 2bcyt and c~scyt primers used for PCR 
bound after addition of an activating antibody, anti-LIBS6, 
confirming that the ligand-binding site was intact (Fig. 3 A). 
Thus, the capacity of cell type-specific elements o modulate 
affinity depends on the integrin cytoplasmic domains. 
Since K562 cells express endogenous O~b under certain 
conditions (12), it was necessary to verify that all of the a~ 
expressed in the ~ chimera transfectants contained the 0~5 
cytoplasmic domain. Immunoprecipitation f c~ chimera 
transfectants with an anti-as cytoplasmic domain antibody 
isolated polypeptides corresponding to transfected ~x~o and 
/33 chimeras and endogenous o~5/3t (Fig. 3 B). In contrast, 
an anti-ol~ cytoplasmic domain antibody immunoprecipi- 
tated no labeled polypeptides. An anti-cx5 cytoplasmic anti- 
body precipitated only endogenous oe5/3~ from wild-type 
ol~3 transfectants. In addition, we confirmed fidelity of ex- 
pression at the mRNA level. Reverse transcriptase PCR was 
performed using a 5' primer specific for the extracellular do- 
main of O~b and 3' primers specific for cytoplasmic do- 
mains of Olnb or 0~5 (Fig. 3 C). A specific 393-bp band was 
observed from c~ chimera transfectants when primed with the 
3' or5 oligonucleotide. A specific 294-bp band was observed 
with wild-type otnb transfectants when primed with the 3' 
ot~ oligonucleotide. No bands were observed when i ap- 
propriate 3' primers were used. 
As was shown in Fig. 1, high affinity Fn binding to ct5/31 
depends on active cellular metabolism. We therefore ana- 
lyzed the effects of NaN3 and 2-deoxyglucose onthe affinity 
state of the double chimera in CHO cells. These inhibitors 
blocked both PAC1 (Fig. 4 A) and Fg (Fig. 4 B) binding. 
Anti-LIBS2, an activating antibody (29), restored high 
affinity binding. Furthermore, the metabolic blockade was 
reversible since high affinity ligand binding reappeared after 
the inhibitors were washed out (Fig. 4 A). These results how 
that c~5/3t cytoplasmic sequences confer a ceil type-specific, 
energy-dependent, high affinity state on the extracellular do- 
main of a.b/~3. 
Both ~ and {3 Cytoplasmic Domains Are Involved in 
Affinity Modulation 
To learn which cytoplasmic domain specified the high 
affinity state in CHO cells, we transfected ach subunit chi- 
mera with a complementary wild-type subunit. Transfec- 
tants expressing both ol and/3 chimeras or expressing the chi- 
meric o~ but wild-type/33 subunits bound PAC1 (Fig. 5 A). 
In contrast, cells expressing the 13 chimera with wild-type 
Ol~b were in a low affinity state and bound PAC1 only after 
addition of anti-LIBS2 (Fig. 5 A). These results show that 
a cytoplasmic sequences are involved in specifying affinity 
state. 
To find out if the/3 subunit was also involved in specifying 
the high affinity state in CHO cells, we constructed two/33 
analysis are illustrated. The transmembrane (TM: crosshatched), 
3' untranslated (3'UZ: stippled), and cytoplasmic and extracellular 
domain (clear) sequences are indicated. RT-PCR was performed as 
described in Materials and Methods with the 5' 2bsf primer and 3' 
primers specific for¢xn~ or c~s 3' untranslated sequences. Amplified 
products were analyzed by agarose gel electrophoresis (b low) with 
arrows denoting the position of he 393 and 294 bp bands. Transfec- 
rant type is listed above while the 3' primer used is noted below. 
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Figure 4. The high affinity state of the c~5 cytoplasmic domain chi- 
mera is energy-dependent. (A) PAC1 binding. Stable CHO transfec- 
tants expressing the u5 and 3~ cytoplasmic domain chimeras were 
assayed for PAC1 binding in the absence (solid line) and presence 
(dotted line) of 2 mM GRGDSP by flow cytometry. Transfectants 
incubated with 2 mg/ml deoxyglucose and 0.1% NaN3 (Inhibitors) 
as described in Materials and Methods manifested loss of specific 
binding. Addition of 6/~M anti-LIBS2 (lnhibitors + Anti-LIBS2) 
or washout of these inhibitors (lnhibitors + Washout) and return 
to glucose-containing medium reconstituted specific PAC1 binding. 
(B) Fibrinogen binding. Stable CHO transfectants expressing the 
cytoplasmic domains noted below were analyzed for fg binding as 
described inMaterials and Methods. Constitutive binding to trans- 
fectants expressing the c~5 chimera with wild-type/33 was inhibited 
by 2 mg/ml deoxyglucose plus 0.1% NAN3; binding to transfec- 
tants expressing the ~',b~991 orat.& variant was not (see below). 
cytoplasmic variants, 33A724 and 33(S752"*'P). The former 
is a truncation mutant hat ends at D 723, while the latter 
contains a single nucleotide alteration resulting in a Set 752-'* 
Pro substitution (Fig. 2). These B3 cytoplasmic domain mu- 
tants were then cotransfected with the o~ chimera. In contrast 
to wild-type B3, coexpression of either 33 variant with chi- 
meric ~ resulted in a receptor that failed to bind PAC1 con- 
stitutively (Fig. 5 B). Thus, the cytoplasmic domain of the 
3 subunit as well as the el subunit is involved in affinity 
modulation. 
Regulation of lntegrin A~nity by the a Subunit 
Cytoplasmic Domain Is cx Subunit-Specific 
These data established that the cytoplasmic domains of O~.b 
and c~5 specify different affinity states in CHO cells; ~,b the 
low and c~5 the high affinity state. To learn whether there 
are consensus activation sequences, we constructed chi- 
meras with the cytoplasmic domains of six additional o~ 
subunits and analyzed their affinity state after cotransfection 
with 33 into CHO ceils. The a cytoplasmic domains of 
three other 3~ family members (at2, c~6A, ct6B) conferred 
PAC1 binding (Fig. 6 a), while those chimeras containing a 
subunit cytoplasmic domains from 32 (arM, OtL) (data not 
shown) or 33(cry) (Fig. 6 A) families did not. The same re- 
sult was obtained with the 3 chimeras containing cytoplas- 
mic domains of the relevant 3 subunit partner (3, for ct2, 
c~v, a6A, and ot6B or 32 for O~L and c~M). Similar to the or5 
chimera, constitutive PAC1 binding was also dependent upon 
the/5 cytoplasmic domain. It was lost when the ct2, ct6A, or 
ot~B chimeras were cotransfected with 33A724 or 33S752P 
(Fig. 6 B). Thus, the a subunit cytoplasmic domain desig- 
nates integrin-specific affinity differences. The 3 subunit cy- 
toplasmic domain may be permissive for the high affinity 
state. 
Deletion of Conserved ~Cytoplasmic Sequences 
Results in High A~inity Ligand Binding 
That Is Independent ofMetabolic Energy and 
the (3 Subunit Cytoplasmic Domain 
We previously reported that constitutive ligand binding to 
Crab33 results from a truncation of the cytoplasmic domain 
of arab (69). To identify the important deleted ctt~ cytoplas- 
mic residues, we generated additional variants. Integrin t~ 
subunit cytoplasmic domains contain a highly conserved 
GFFKR sequence at their NH2 termini (Fig. 2). As previ- 
ously reported (69, 97), the o~abA991 truncation eliminates 
this motif and results in constitutive PAC1 binding (Fig 7 A; 
panel A) whereas a truncation after the GFFKR (CtnbA996) 
does not (Fig. 7 A; panel C). This pinpoints the conserved 
motif as a regulator of integrin affinity. To test this idea, we 
removed the LGFFK residues from the cytoplasmic domain 
of an ell cytoplasmic domain chimera (Fig. 2). This chi- 
mera was selected because it possesses the longest o~ cyto- 
plasmic domain. Coexpression of this chimeric internal de- 
letion mutant (actS) in CHO cells with 33 resulted in high 
affinity PAC1 binding (Fig. 7 B, panel A). Finally, to further 
exclude contributions from downstream ¢x sequences, we 
generated a variant hat contains a24-residue random cyto- 
plasmic sequence (Fig 2). This construct (O~R.) alSO con- 
ferred high affinity binding when expressed in CHO cells 
with wild-type 33 (Fig. 7 A; panel B). 
To gain insight into the mechanisms ofhigh affinity bind- 
ing conferred by the GFFKR deletion mutants, we examined 
the requirements for cellular metabolism and 3 cytoplasmic 
sequences. In contrast to the constitutively active chimeras, 
high affinity PAC1 binding in the GFFKR deletion variants 
was maintained when they were coexpressed with the trun- 
cated 33 subunit (Fig. 7 B; panel B). In addition, in con- 
trast to transfectants expressing constitutively active ¢x 
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Figure 5. Role of both t~ and B 
cytoplasmic domains in af- 
finity modulation. (.4) The c~ 
subunit cytoplasmic domain 
specifies affinity state. CHO 
cells were transiently trans- 
feeted with subunits com- 
prised of the extracellniar and 
transmembrane domains of 
am and 53 joined to the indi- 
cated cytoplasmic domains. 
The affinity state of the ex- 
traeellular portion of txmB3 
was assessed by PAC1 bind- 
rag. Binding was analyzed 
in the absence (solid line) 
or presence (dotted line) 
of GRGDSP peptide. Histo- 
grams of cells incubated in the 
presence of 6/~M anti-LIBS2 
are depicted in the lower 
panels. Specific PAC1 binding 
is present in both transfectants 
containing the a5 cytoplasmic 
domain irrespective of the 
presence of either the/53 or/~l 
cytoplasmic domain on the/~3 
subunit. In contrast, PAC1 
specifically bound to those 
transfectants containing the 
c~nb cytoplasmic domain only 
in the presence of the activat- 
ing antibody, anti-LIBS2. (B) 
Affinity state is dependent 
upon the /~3 cytoplasmic do- 
main. Stable CHO cell lines 
expressing recombinant t~m~3 
chimeras containing the noted 
cytoplasmic domains were 
reacted with PAC1 and bound 
antibody was detected by flow 
cytometry as described in 
Materials and Methods. Bind- 
ing was analyzed in the ab- 
sence (solid line) or presence 
(dotted line) of GRGDSP pep- 
tide. The intrinsic functional- 
ity of each construct was as- 
sessed by PAC1 binding in the 
presence of 6/~M anti-LIBS2 
(lower panels). A ~3 cyto- 
plasmic truncation (A724) 
and single amino acid substi- 
tution(S752~p) both abol- 
ished the constitutive high 
affinity s ta te  conferred by the 
cytoplasmic domain of ets. 
chimeras, transfectants expressing the GFFKR deletions re- 
tained high affinity for Fg (Fig. 4 B) and PAC1 (Fig. 7 B; 
panel C) when treated with the metabolic inhibitors NaN3 
and 2-deoxyglucose. Finally, the OtLA mutant conferred 
cell-type independent activation, since it was active in K562 
(Fig, 7 B; panel D) and COS (not shown) as well as CHO 
cells. Thus, deletions in the highly conserved GFFKR motif 
resulted in a cell type-independent high affinity state that was 
resistant o metabolic inhibitors and truncation of the /3 
subunit. 
Discussion 
The major findings of this work are (a) the affinity s ta te  of 
integrin ot~Bt is regulated by cell type-specific factors. The 
high affinity state requires active cellular processes suggest- 
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Figure 6. Affinity state is c~ subunit cytoplasmic domain specific. 
(A) Effect of different tx cytoplasmic domains. Chimeric ~ subunits 
consisting of extracellular nd transmembrane c~n~ with the indi- 
cated cytoplasmic domain were transiently cotransfected with/33 
into CHO cells. PAC1 binding was quantified by flow cytometry and 
the activation index was calculated as: 100*(Fo-FR)/FR where: 
Fo = Mean Fluorescence Intensity in the absence of inhibitor; 
FR = Mean Fluorescence Intensity in the presence of 2 mM 
GRGDSP. Depicted are the mean + SD of at least hree independent 
experiments for each ~x chimera. (B)/3 Subunit cytoplasmic domain 
dependence of the high affinity state, tx Subunit chimeras contain- 
ing the indicated cytoplasmic sequences were cotransfected with a 
/33 subunit whose cytoplasmic domain was truncated (f13A724), 
contained the $752~P mutation ($752P), or had been exchanged 
for the homologous region of/3~. PAC1 binding was analyzed as 
described in panel A. Mean 4- SD of at least hree independent ex- 
periments for each c¢/3 pair. 
ing that low affinity may be the default state. (b) Cell type- 
specific signals that modulate integrin affinity are trans- 
mired through the cytoplasmic domains. Both cytoplasmic 
domains are involved in these signaling events. (c) Certain 
deletions in the conserved GFFKR sequence inthe c~ subunit 
cytoplasmic domain reset he default state to high affinity. In 
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Figure 7. GFFKR deletion variants confer an energy and/3 subunit 
cytoplasmic domain-independent high affinity state. (.4) GFFKR 
sequence deletion activates c~/33. Stable CHO cell lines were es- 
tablished by cotransfection f c~nb containing the noted c~ cytoplas- 
mic domain with wild-type/33. PAC1 binding in the absence (solid 
line) and presence (dotted line) of GRGDSP was assessed by flow 
cytometry. The ,,m, A991 transfectant, which lacks GFFKR, 
specifically binds PAC1 (panel A). In contrast, he <xm,A996 trans- 
fectant, which retains GFFKR, binds only after activation with 
anti-LIBS2 (panels C and D). P-_cplacement of the ce~ cytoplasmic 
domain with random sequence also induces PAC1 binding (panel 
B, av.,). (B) Energy,/3 subunit cytoplasmic domain, and cell type- 
independent high affinity state of GFFKR deletion variants. CHO 
cells were transiently transfccted with chimeras of the extracellnlar 
and transmembrane domains of Ctnb/33 joined to the indicated cyto- 
plasmic domains. Specific PAC1 binding to the population of cells 
expressing cxnb/33 was detected as described in Fig. 7 A. A GFFKR 
"loop out" mutant manifested PAC1 binding (panel A) that was 
maintained in the presence of 0.1% NaN3 and 2 mM 2-deoxyglu- 
case (panel C). This treatment abolished ligand binding to an 
ctm,/33 chimera bearing the cytoplasmic domain of c~5/31 (not 
shown, but of. Fig. 4 A). High affinity state was also maintained 
despite an extensive deletion of the/33 cytoplasmic domain (panel 
B) that disrupted PAC1 binding to the as/3~ chimera (not shown 
but cf. Fig. 5 B). Similar esults were obtained with tx~oA991 and 
cth transfeetants. A stable K562 cell line bearing the GFFKR de- 
letion mutant specifically bound PAC1 (panel D), but the c~s/3~ chi- 
mera was not active in these cells (cf. Fig. 3 A). 
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Table L Summary of Affinity States of the Extracellular Domain: Physiological Modulation 
~3 ~3A724 ~3S752P 81 ~2 
~I/b LO LO LO LO - 
or2 HI  LO LO HI  - 
aS  HI  LO LO HI  - 
ct6A HI LO LO HI  - 
.6B  HI LO LO HI  - 
~L  LO - - - LO 
c~M LO - - - LO  
~v LO . . . .  
Summary of the affinity states, as assayed by PAC1 binding to CHO ceils transiently transfected with chimeras of the extraceUular nd transmembrane domains 
of c~n~ joined to the indicated cytoplasmic domains. Affinity states were defined as HI = Activation Index ;~60 and LO = Activation Index ~45. Double 
underlining indicates the experiments hat establish the importance of the ~ subunit cytoplasmic domain in maintenance of the high affinity state. In all instances 
of the high affinity state, treatment with NaN3 and 2-deoxyglucose r sulted in reversion to the low affinity state. 
these deletion mutants, the high affinity state is independent 
of cell type, and is not blocked by metabolic inhibitors or by 
near complete truncation of the/3 subunit tail. These studies 
show that he cytoplasmic domains of integrins control their 
affinity state. Thus, these domains become attractive targets 
for approaches toalter cell adhesion. Further, the conserved 
GFFKR motif of the u subunit cytoplasmic domain main- 
tains the default low affinity of the extracellular domain. 
The ligand-binding affinity of integrin c~5/~ depends on 
the cell type in which it is found. Such differences in ligand- 
binding affinity could well account for previous reports of 
cellular variation in the adhesive function of integrins 0, 15, 
25, 35, 49, 55, 62, 66, 94). It is possible that cell type- 
dependent affinity differences are due to structural variations 
in ots#~ synthesized in the different cell types. Permanent 
structural variants (e.g., alternative splicing [5, 11, 41, 42, 
92], alternative proteolytic processing [58]) can be excluded 
as the sole cause of the affinity differences reported here be- 
cause the affinity of o~5#~ was reversibly decreased by meta- 
bolic inhibitors. Consequently, the increased affinity of 
c~5/~ in CHO cells seems the result of active cellular sig- 
nais. Since the metabolic inhibitors caused the reversion of 
oc5/~ to the low affinity state, it seems that low affinity is the 
default state of ~5/3~. Similarly o~n~/33 and ~./~2 usually re- 
quire active cellular processes for high affinity ligand bind- 
ing (4, 61). Furthermore, purified c~trd33 in liposomes pon- 
taneously reverts to low affinity after removal of activating 
ligands (84). Thus, default low affinity state may be a general 
property of integrins. 
Signals that modulate the affinity of o~5/~t are targeted 
through the integrin's cytoplasmic domains. Joining the cyto- 
plasmic domains of ~/3~ onto the extracellular nd trans- 
membrane domains of O~zrd~3, an exchange involving less 
than 5 % of the total mass of the integrin, caused the o~n~/~3 
to assume the high affinity state in CHO cells. Biologically 
relevant signals mediated the increased affinity of the chi- 
mera since: (a) it was cell-type specific, (b) it could be reset 
to the default low affinity by addition of inhibitors of oxida- 
tive phosphorylation a d anaerobic glycolysis, and (c) a B3 
cytoplasmic domain mutation ($752--'P) returned the chi- 
meric integrin to the low affinity state. This naturally occur- 
ring mutation is associated with defective activation of 
o~mfl3 in platelets (16). Cell-type specific signaling elements 
that interact with the integrin cytoplasmic domains could 
readily explain the distinctive cellular influences on integrin 
affinity. In view of the marked sequence divergence of the ¢x 
subunit ails (Fig. 2), multiple such integrin-specific ele- 
ments might exist. 
As summarized in Table I, the a subunit cytoplasmic do- 
main designated integrin-specific differences in affinity state. 
In CHO cells, ors, ot~A and B, and o~2 cytoplasmic tail 
chimeras specified the high affinity state. The ot~,A996 
truncation mutant leaves the common (Fig. 2) KXGFFKR 
motif and results in a low affinity state. This suggests hat ac- 
tivation signaling sequences important for conversion of the 
integrin to a high affinity state reside carboxyterminal of 
GFFICR in as, ot6A and B, and a2. Thus, deletion of related 
sequences could account for the reduction of cell adhesion 
by certain truncations of the a4 (45) or o~2 (46) cytoplasmic 
tail. In addition, truncations of O~nb or o~ that retain 
GFFKR lose the capacity to constrain integrin localization 
to focal adhesions (9, 97). This result suggests he existence 
of elements within the carboxyl terminal portion of the ot 
subunit hat inhibit targeting of the integrin to focal adhe- 
sions. In CHO cells, the full-length O~nb cytoplasmic do- 
main specifies a low affinity state but still constrains the lo- 
calization of ~b/~3 to focal adhesions. Thus, we suspect that 
the o~ cytoplasmic domain elements hat control targeting to 
focal adhesions and ligand-binding affinity are not identical. 
These elements may also be involved in the role of c~ subunit 
cytoplasmic domains in more complex cellular functions 
such as collagen gel contraction, cell migration, and cell 
adhesion (14, 45, 46). 
The cytoplasmic domains of either/3~ or/33 were required 
for the activation of the ot subunit chimeras. Moreover, the 
capacity of #3($752---P) to disrupt activation, underscores 
the specificity of the B subunit requirement. Interestingly, 
/~3 Ser TM is homologous to a Thr (Fig. 2) involved in the 
adhesive function of art2 (38). S 752 is not extensively phos- 
phorylated in platelets (40). We have found no obvious 
difference in the phosphorylation f as cytoplasmic domain 
chimeras in CHO cells and K562 cells (unpublished results). 
Thus, the mechanism of the effect of the $752--*P mutation 
on inside-out signaling remains to be resolved. 
Mutations that delete portions of the conserved GFFKR 
sequence appear to reset c~m~3 to a default high affinity 
state. As summarized in Table II, a truncation mutant hat 
removes this sequence (OtnbA991) is constitutively active, 
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Table II. Summary of Affinity States of the Extracellular 
Domain: Hinge Mutants 
83 ~3A 724 ~3S752P 
edlb LO LO LO 
odlbA991 HI* HI HI 
odlbA996 LO* LO LO 
c~LA HI* HI HI 
LO* - - 
c~Ra HI* HI HI 
Summary of the affinity states of the extracellular domains of am~3 when 
joined to the indicated cytoplasmic domains and transiently expressed in CHO 
cells as assayed by PACI binding. Affinity states were defined as HI  = 
Activation Index )60 and LO = Activation Index ~45. Asterisks indicate the 
experiments establishing the role of the GFFKR motif in maintenance of the 
low affinity state. Double underlining indicates the experiments that establish 
the lack of importance of the ~ subunit cytoplasmic domain in supporting the 
high affinity state in these mutants. In all instances of the high affinity state, 
treatment with NaN3 and 2-deoxyglucose did not result in reversion to the 
low affinity state. 
whereas a truncation that retains this sequence (ot~,A996) 
remains inactive. Moreover, a KLGFF loop out mutation in 
the ~L cytoplasmic domain or replacement of the c~ cyto- 
plasmic domain with a 24-residue random sequence also 
resulted in high affinity Fg and PAC1 binding. The nature of 
the high affinity state in these GFFKR mutants differed 
markedly from that in the cytoplasmic domain chimeras. 
Specifically, the deletions resulted in default high affinity in 
all cells tested. In addition, high affinity was maintained e- 
spite addition of metabolic inhibitors and truncation f the 
13 cytoplasmic domain. Of note in this context, a truncated 
o~5, lacking GFFKR, is more efficient at assembling a Fn 
matrix than wild-type e¢5 (96). This effect could be  due  to 
increased Fn binding, since matrix assembly may be regu- 
lated by the affinity state of o~5/31 (26). The GFFKR se- 
quence probably resides in the cell interior because there are 
generally about 20 hydrophobic residues preceding the 
charged Lys of the KXGFFKR motif (6, 18, 19, 54, 72, 83, 
88-91). Mutations of intramembrane or cytoplasmic (13, 56, 
73) residues can lead to constitutive transmembrane confor- 
mational changes in other receptors. In integrins, certain 
cytoplasmic domain mutations also initiate such a constitu- 
tive transmembrane alteration. 
The high affinity state of otmg3 provoked by deletion of 
GFFKR suggests possible mechanisms for transmembrane 
signaling through integrins. Transmembrane domains of 
type I membrane proteins uch as integrin ot and/3 subunits 
are presumably constrained into helices (83). Consequently, 
transmission ofcon~rmafional information across the mem- 
brane probably involves changes in the spatial relationships 
of the ot and/5 subunits. The bacterial aspartate r ceptor, like 
integrins (63), has ligand contact sites in each of its two 
Figure 8. Working hypotheti- 
cal model of affinity modula- 
tion of integrins. Depicted is a 
schematic that accommodates 
the results reported here. Cell- 
type specific energy-depen- 
dent cytoplasmic signals tar- 
get the integrin cytoplasmic 
domains. The unidentified fac- 
tor(s) responsible for these sig- 
nals (represented as lntegrin 
Actimtor Complex) interacts 
with the cytoplasmic domains 
to provoke changes in the spa- 
tial relationships or conforma- 
tions of the c~ and ~ subunit 
cytoplasmic tails. Such changes 
then traverse the membrane- 
proximal GFFKR sequence to 
alter the relationship of a and 
/3 subunit transmembrane do- 
mains and ultimately the con- 
formation of the extraceUular 
domain. Although the ac- 
tion is depicted asa scissors, 
other motions such as pistons, 
seesaws, or rotation (47, 87) 
of the subunits are also pos- 
sible. Since these motions 
must traverse GFFKR to reach 
the transmembrane domains, 
GFFKR could be vi~,ved as a 
component ofa hinge that con- 
nects the cytoplasmic and 
the transmembrane domains. 
Thus, deletions in GFF IGR lock 
the integrin hinge in an irre- 
versible high affinity state: 
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membrane-spanning subunits. Ligand binding results in a 1.4 
]~ shift of membrane-adjacent helices relative to each other. 
This shift may result in outside-in signaling. In integrins, the 
cytoplasmic GFFKR sequence could regulate the spatial 
relationships of the ot and/3 subunits through interactions 
with the j3 subunit resulting in inside-out signaling. Alterna- 
tively, GFFKR could bind membrane lipids and perturba- 
tions of such interactions could explain lipid modulation of 
integrin function (17, 37, 84). Finally, cytoplasmic proteins 
could bind to this sequence. Calreticulin, a protein usually 
thought to reside in the endoplasmic reticulurn, has been 
reported to bind to a short synthetic peptide containing 
GFFKR (74). If this association occurs in vivo, then the 
calreticulin-GFFKR interaction or one like it may set the 
integrin's default affinity state. A search of the Swissprot 
Database, using Wordsearch (21), identified the GFFKR se- 
quence in several C4 zinc finger ("steroid fingers n) transcrip- 
tion factors (e.g., retinoic acid receptor [60], Drosophila 
tailless [70], Nur/77 [76]). The sequence is in the most 
highly conserved site in this receptor family (27, 77, 78). 
Moreover, in the glucocorticoid receptor, this region forms 
part of an alpha helix that is initiated by two zinc-coordinat- 
ing cysteines (59). This helix forms contacts with DNA that 
are critical for activity (27, 59, 77). In integrins, KXGFFKR 
presumably adjoins an c~ helix. By analogy with the steroid 
fingers, GFFKR may therefore possess ot helical structure 
and participate in functionally important interactions. 
The data presented here suggest a working hypothesis for 
affinity modulation of integrins (Fig. 8). Cell-type specific 
and energy-dependent cytoplasmic signals target the integrin 
cytoplasmic domains. The unidentified factor(s) responsible 
for these signals (represented as IAC in Fig. 8) require the 
presence of elements of both cytoplasmic domains. The IAC- 
cytoplasmic domain interaction could provide changes in the 
spatial relationships or conformations of the c~ and/3 subunit 
cytoplasmic tails. Such changes then probably traverse the 
membrane-proximal GFFKR sequence to influence the rela- 
tionship of o~ and/3 subunit ransmembrane domains and ulti- 
mately the conformation of the extracellular domain. Al- 
though the action is depicted as a %cissors" in Fig. 8, other 
motions such as "pistons; "seesaws; or rotation (47, 87) of 
the subunits are also possible. Since these motions must 
traverse GFFKR to reach the transmembrane domains, 
GFFKR could be viewed as a component of a "hinge" that 
connects the cytoplasmic and the transmembrane domains. 
Thus, deletions in GFFKR might lock the integrin hinge in 
an irreversible high affinity state (Fig. 8). In theory, other 
mutations might lock the hinge in a low affinity state. 
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